Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefotetan disodium injection vs cefmetazole sodium for acute respiratory and urinary bacterial infections
CTR20131216Phase 2Completed
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cefotetan in acute bacterial respiratory infection (ABRI), Acute Bacterial Urinary Tract Infection (UTI), sponsored by Yangtze River Pharmaceutical Group. Started Jan 2014; status: completed.
02
Drugs
cefotetan
03
Conditions
acute bacterial respiratory infection (ABRI)Acute Bacterial Urinary Tract Infection (UTI)
Beyond the preview
Go deeper on CTR20131216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131216.